Literature DB >> 6234036

Characterization of immature T cell subpopulations in neonatal blood.

S Griffiths-Chu, J A Patterson, C L Berger, R L Edelson, A C Chu.   

Abstract

A series of monoclonal antibodies directed against T cell differentiation antigens was used to identify circulating T cells in normal human neonates. Twenty-five cord blood samples, taken after cesarean or vaginal delivery, and 16 venous blood samples from normal adult controls were examined using monoclonal antibodies in an indirect immunofluorescence technique. The percentage of circulating OKT3 positive (pan-T cell) cells was significantly lower in the neonatal blood (52.8%) compared with the adult controls (74.9%) (P less than .001). Of the cord mononuclear cells, 58% showed reactivity with OKT10 (common thymocyte antigen) compared with only 7% in adult controls (P less than .001). The helper:suppressor T cell ratio was lower in cord blood (1:2) as compared with 1:3 for adult blood (P less than .005) as observed in these studies. These figures reflect the presence of a significant population (25%) of immature T cells in cord blood that expresses simultaneously both helper (OKT4) and suppressor (OKT8) phenotypes. Twenty-four percent of the T cells in cord blood also expressed OKT6 antigen (cortical thymocyte), a feature not found in adult blood. Double-labeling studies characterized a previously undescribed blood T cell phenotype, which was simultaneously OKT6 and OKT3 (pan-T cell) positive; of the cells reactive with OKT3, 43% also were positive with OKT6. This study reveals the presence of immature populations of T cells in normal human neonatal blood exhibiting phenotypes characteristic of normal developing thymocytes and a previously undescribed cell phenotype.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6234036

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes.

Authors:  D T Harris; M J Schumacher; J Locascio; F J Besencon; G B Olson; D DeLuca; L Shenker; J Bard; E A Boyse
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

2.  Clonal analysis of CD4+/CD8+ T cells in a patient with aplastic anemia.

Authors:  U Moebius; F Herrmann; T Hercend; S C Meuer
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

3.  Circulating CD4+CD8+ T lymphocytes in patients with Kawasaki disease.

Authors:  J Hirao; K Sugita
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

4.  The role of interleukin 2 in the regulation of proliferation and IgM synthesis of human newborn mononuclear cells.

Authors:  J Punnonen
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

5.  Alterations in helper-inducer and suppressor-inducer T-cell subsets in human neonatal blood.

Authors:  R Landesberg; M Fallon; R Insel
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

6.  Signalling via CD28 of human naive neonatal T lymphocytes.

Authors:  J Hassan; S O'Neill; L A O'Neill; U Pattison; D J Reen
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

7.  Phenotypic and functional analysis of human T lymphocytes in early second- and third-trimester fetuses.

Authors:  Y Zhao; Z-P Dai; P Lv; X-M Gao
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

8.  Age-related changes in blood lymphocyte subsets of Saudi Arabian healthy children.

Authors:  S Shahabuddin; I Al-Ayed; M O Gad El-Rab; M I Qureshi
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

9.  High numbers of autoantigen-reactive mononuclear cells expressing interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) are present in cord blood.

Authors:  M Yu; S Fredrikson; J Link; H Link
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

10.  Circulating CD3+ CD4+ CD8+ T lymphocytes in multiple sclerosis.

Authors:  F E Munschauer; C Stewart; L Jacobs; S Kaba; Z Ghorishi; S J Greenberg; D Cookfair
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.